Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response.

× No keyword cloud information.

15 in total

1. Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer.

Authors: D de Vos; P H Slee; D Stevenson; R J Briggs
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 2. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors: P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal: Clin Pharmacokinet Date: 1992-05 Impact factor: 6.447

3. The bioavailability of Tamoplex (tamoxifen). Part 3. A steady-state study in breast cancer patients.

Authors: P H Slee; D De Vos; D Chapman; D Stevenson
Journal: Pharm Weekbl Sci Date: 1988-02-19

4. Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer.

Authors: Changde Zhang; Qiu Zhong; Qiang Zhang; Shilong Zheng; Lucio Miele; Guangdi Wang
Journal: Breast Cancer Res Treat Date: 2015-06-14 Impact factor: 4.872

Review 5. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors: V Craig Jordan
Journal: Steroids Date: 2007-07-27 Impact factor: 2.668

Review 6. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors: M M Buckley; K L Goa
Journal: Drugs Date: 1989-04 Impact factor: 9.546

7. Tamoxifen (Nolvadex) therapy--radionale for loading dose followed by maintenance dose for patients with metastatic breast cancer.

Authors: P M Wilkinson; G G Ribiero; H K Adam; J V Kemp; J S Patterson
Journal: Cancer Chemother Pharmacol Date: 1982-12 Impact factor: 3.333

Review 8. Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors: P N Plowman
Journal: Drugs Date: 1993-11 Impact factor: 9.546

9. Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer.

Authors: S R Johnston; B P Haynes; N P Sacks; J A McKinna; L J Griggs; M Jarman; M Baum; I E Smith; M Dowsett
Journal: Breast Cancer Res Treat Date: 1993-12 Impact factor: 4.872

Review 10. Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors: V C Jordan
Journal: Breast Cancer Res Treat Date: 1982 Impact factor: 4.872